In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 214894-89-0, name is 5-(Bromomethyl)-2,3-dihydro-1,4-benzodioxine, introducing its new discovery. HPLC of Formula: C9H9BrO2
Cyclohexanecarbonylic acid ethyl ester derivatives
A liquid crystal compound having a positive value of dielectric anisotropy and a low viscosity and being capable of extending the mesomorphic range of liquid crystal composition toward its lower region, and a liquid crystal composition containing the same are provided, which compound is a trans-4-substituted-cyclohexanecarboxylic acid beta-(4-halogenophenyl) ethyl ester derivative expressed by the general formula STR1 wherein R1 represents R2, STR2 wherein R2 represents an alkyl group or an alkoxy group, each having 1 to 15 carbons and X represents F or Cl.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 214894-89-0, and how the biochemistry of the body works.HPLC of Formula: C9H9BrO2
Reference£º
Benzodioxan,
1,4-Benzodioxane | C8H8O2 – PubChem